Delivery Order SPE2DB20D3101-SPE2DB25FRQS2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Trokendi XR 100 mg capsules. The firm fixed price contract has a potential value of $2,067.97 and a completion date of December 28, 2023. Amerisourcebergen Drug Corp, operating through its Corporate Office division, has an extensive history of providing pharmaceutical products and medical supplies to DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $5,403.67 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count) on July 11, 2025, with completion scheduled for July 14, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a $29,860.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Trokendi XR 200 mg capsules (30-count units). The award was made without a set-aside designation through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location. This delivery order represents a child contract action under the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,180.32 to AmerisourceBergen Drug Corp for Trokendi XR 50 mg capsules (30-count) on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price, non-set-aside delivery order was placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. The product will be...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,115.29 by the Defense Logistics Agency (DLA) on November 26, 2025, for the supply of Trokendi XR 200 mg capsules in quantities of 30 units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 28, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,698.07 to AmerisourceBergen Drug Corp for Trokendi XR 25 mg capsules (30-count units) on October 28, 2025, with completion scheduled for October 29, 2025. This is a firm fixed-price, non-set-aside delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a total value of $999,999,999 and extends through December 2026. The product will...
- The Defense Logistics Agency awarded a $4,622.34 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Trokendi XR 200 mg capsules (30-count units). This non-set-aside contract was competitively awarded and is scheduled for completion by August 21, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $25,401.53 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 200 mg capsules (30-count units) under a firm fixed-price contract type. The award was made on November 6, 2025, with an ultimate completion date of November 7, 2025, and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,833.96 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count) on August 13, 2025. This is a firm fixed price, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 14, 2025. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $7,207.55 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count) under a firm fixed-price arrangement. The contract, which was competitively awarded without set-aside designation, is scheduled for completion by September 24, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRQS2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,689.54 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count). This firm fixed-price, competitively awarded contract with no set-aside designation was executed on July 21, 2025, with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, functions as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's DLA SPE2DX prime contract enables supply of a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This specific delivery order for Trokendi XR (an antiepileptic medication) exemplifies the company's role in supporting Defense Health Agency medical supply needs through the DLA's Troop Support Medical Supply Chain, demonstrating AmerisourceBergen's capability to fulfill federal healthcare requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/21/25 |